Center on Society and Health, Virginia Commonwealth University, 830 East Main Street, Richmond, VA 23298-0212, USA; Department of Family Medicine and Population Health, Virginia Commonwealth University, VA, USA
Center on Society and Health, Virginia Commonwealth University, 830 East Main Street, Richmond, VA 23298-0212, USA; Department of Family Medicine and Population Health, Virginia Commonwealth University, VA, USA.
BMJ. 2018 Aug 15;362:k3096. doi: 10.1136/bmj.k3096.
To systematically compare midlife mortality patterns in the United States across racial and ethnic groups during 1999-2016, documenting causes of death and their relative contribution to excess deaths.
Trend analysis of US vital statistics among racial and ethnic groups.
United States, 1999-2016.
US adults aged 25-64 years (midlife).
Absolute changes in mortality measured as average year-to-year change during 1999-2016 and 2012-16; excess deaths attributable to increasing mortality; and relative changes in mortality measured as relative difference between mortality in 1999 versus 2016 and the nadir year versus 2016, and the slope of modeled mortality trends for 1999-2016 and for intervals between joinpoints.
During 1999-2016, all cause mortality in midlife increased not only among non-Hispanic (NH) whites but also among NH American Indians and Alaskan Natives. Although all cause mortality initially decreased among NH blacks, Hispanics, and NH Asians and Pacific Islanders, this trend ended in 2009-11. Drug overdoses were the leading cause of increased mortality in midlife in each population, but mortality also increased for alcohol related conditions, suicides, and organ diseases involving multiple body systems. Although midlife mortality among NH whites increased across a multitude of conditions, a similar trend affected non-white populations. Absolute (year-to-year) increases in midlife mortality among non-white populationsoften matched or exceeded those of NH whites, especially in 2012-16, when the rate of increase intensified for many causes of death. During 1999-2016, NH American Indians and Alaskan Natives experienced large increases in midlife mortality from 12 causes, not only drug overdoses (411.4%) but also hypertensive diseases (269.3%), liver cancer (115.1%), viral hepatitis (112.1%), and diseases of the nervous system (99.8%). NH blacks experienced increased midlife mortality from 17 causes, including drug overdoses (149.6%), homicides (21.4%), hypertensive diseases (15.5%), obesity (120.7%), and liver cancer (49.5%). NH blacks also experienced retrogression: after a period of stable or declining midlife mortality early in 1999-2016, death rates increased for alcohol related liver disease, chronic lower respiratory tract disease, suicides, diabetes, and pancreatic cancer. Among Hispanics, midlife mortality increased across 12 causes, including drug overdoses (80.0%), hypertensive diseases (40.6%), liver cancer (41.8%), suicides (21.9%), obesity (106.6%), and metabolic disorders (60.0%). Retrogression also occurred in this population; after a period of declining mortality, death rates increased for alcohol related liver disease, mental and behavioral disorders involving psychoactive substances, and homicides. NH Asians and Pacific Islanders were least affected by this trend but also experienced increases in midlife mortality from drug overdoses (300.6%), alcohol related liver disease (62.9%), hypertensive diseases (28.3%), and brain cancer (56.6%). The suicide rate in this group increased by 29.7% after 2001. The relative increase in US midlife mortality differed by sex and geography. For example, the relative increase in fatal drug overdoses was greater among women than among men. Although the relative increase in midlife mortality was generally greater in non-metropolitan (ie, rural) areas, the relative increase in drug overdoses among NH whites and Hispanics was greatest in suburban fringe areas of large cities, and among NH blacks was greatest in small cities.
Mortality in midlife in the US has increased across racial-ethnic populations for a variety of conditions, especially in recent years, offsetting years of progress in lowering mortality rates. This reversal carries added consequences for racial groups with high baseline mortality rates, such as for NH blacks and NH American Indians and Alaskan Natives. That death rates are increasing throughout the US population for dozens of conditions signals a systemic cause and warrants prompt action by policy makers to tackle the factors responsible for declining health in the US.
系统比较 1999 年至 2016 年期间美国不同种族和族裔群体中年期死亡率模式,记录死亡原因及其对超额死亡的相对贡献。
对美国不同种族和族裔群体的美国人口动态统计数据进行趋势分析。
美国,1999-2016 年。
年龄在 25-64 岁之间的美国成年人(中年)。
1999-2016 年和 2012-16 年平均每年死亡率变化的绝对变化;死亡率增加导致的超额死亡;以及 1999 年与 2016 年死亡率的相对差异、死亡率最低年份与 2016 年死亡率的相对差异以及 1999-2016 年和各时间段连接点之间死亡率趋势模型的斜率。
1999-2016 年,非西班牙裔(NH)白种人以及 NH 美洲印第安人和阿拉斯加原住民的中年全因死亡率均呈上升趋势。尽管 NH 黑种人、西班牙裔和 NH 亚洲及太平洋岛民的全因死亡率最初有所下降,但这一趋势在 2009-11 年结束。药物过量是每个群体中年期死亡率增加的主要原因,但与酒精相关的疾病、自杀和涉及多个身体系统的器官疾病也导致了死亡率的增加。尽管 NH 白种人中年死亡率在多种情况下增加,但这一趋势也影响了非白种人群。非白人群的中年死亡率(每年)增长往往与 NH 白种人相当,甚至超过了 NH 白种人,尤其是在 2012-16 年,当时许多死因的死亡率增加速度加快。1999-2016 年,NH 美洲印第安人和阿拉斯加原住民因 12 种原因导致中年死亡率大幅上升,不仅包括药物过量(411.4%),还包括高血压疾病(269.3%)、肝癌(115.1%)、病毒性肝炎(112.1%)和神经系统疾病(99.8%)。NH 黑种人因 17 种原因导致中年死亡率增加,包括药物过量(149.6%)、凶杀(21.4%)、高血压疾病(15.5%)、肥胖症(120.7%)和肝癌(49.5%)。NH 黑种人也出现了倒退:在 1999-2016 年早期死亡率稳定或下降的一段时间后,与酒精相关的肝病、慢性下呼吸道疾病、自杀、糖尿病和胰腺癌的死亡率上升。在西班牙裔中,中年死亡率因 12 种原因而上升,包括药物过量(80.0%)、高血压疾病(40.6%)、肝癌(41.8%)、自杀(21.9%)、肥胖症(106.6%)和代谢紊乱(60.0%)。这一人群也出现了倒退:在死亡率下降一段时间后,与酒精相关的肝病、涉及精神活性物质的精神和行为障碍以及凶杀的死亡率上升。NH 亚洲及太平洋岛民受这一趋势影响最小,但也因药物过量(300.6%)、酒精相关的肝病(62.9%)、高血压疾病(28.3%)和脑癌(56.6%)而导致中年死亡率增加。自 2001 年以来,该人群的自杀率上升了 29.7%。美国中年死亡率的相对增加因性别和地理位置而异。例如,女性药物过量死亡率的相对增加大于男性。尽管中年死亡率的相对增加总体上在非大都市地区(即农村地区)更大,但 NH 白人和西班牙裔的药物过量死亡率相对增加在大城市郊区边缘地区最大,NH 黑种人的药物过量死亡率相对增加在小城市最大。
美国不同种族和族裔群体的中年死亡率因多种原因而上升,尤其是近年来,这抵消了死亡率下降多年的成果。这种逆转对基线死亡率较高的种族群体,如 NH 黑人和 NH 美洲印第安人和阿拉斯加原住民,带来了额外的后果。几十种疾病的死亡率在美国人口中都在增加,这表明存在系统性原因,政策制定者应迅速采取行动,解决导致美国健康状况下降的因素。